FDA approves fingolimod drug for multiple sclerosis
Links shared publicly online about this topic.
- 852total visits
FDA approves fingolimod drug for multiple sclerosis
View full resource at news-medical.net
Tags: Multiple Sclerosis, Drug, FDA, Physician
Most Recently Shared on September 23, 2010 at 2:09 pm By:
FDA approves fingolimod drug for multiple sclerosis: The first oral medication for multiple sclerosis was approved... http://bit.ly/csWCyo
Symposier - Andrew Goodman, M.D. discusses new drug for Multiple Sclerosis | Joeygiggles Health Topics | Scoop.it
scoop.it — “Uploaded and Shared in Youtube by: URMCPR — A new treatment for multiple sclerosis (MS) that improves mobility for some patients earned FDA approval in January 2010.” View full resource at scoop.it
Most Recently Shared on March 18, 2012 at 5:27 pm By:
Symposier - Andrew Goodman, M.D. discusses new drug for Multiple Sclerosis | @scoopit via @SympoNeurology http://t.co/qFOFdE28 pls Rt #JGF
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients | Mail Online
dailymail.co.uk — “The NHS rationing body has approved the drug fingolimod which can halve relapses among sufferers compared with standard treatments.” View full resource at dailymail.co.uk
Most Recently Shared on March 17, 2012 at 12:56 pm By:
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients: The NHS rationing bo... http://t.co/deH3thL6
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients - QualityPoint Technologies
qualitypointtech.net — “The NHS rationing body has approved the drug fingolimod which can halve relapses among sufferers compared with standard treatments. (Source: the Mail online | Health)” View full resource at qualitypointtech.net
Most Recently Shared on March 17, 2012 at 12:00 pm By:
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients: The NHS rationing body... http://t.co/iHvUwA2D
Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis - MarketWatch
marketwatch.com — “Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on February 28, 2012 at 1:40 pm By:
John Carroll Health Communicator
Biogen Idec files NDA for MS drug BG-12 http://t.co/UZzyHMjU #biotech
Patient Died Soon After Taking MS Drug Fingolimod : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on December 20, 2011 at 9:35 pm By:
Bob Finn - Medical News Net Health News
FDA reports that a patient died soon after the first dose of multiple sclerosis drug fingolimod - http://t.co/0wXIZGAl
FDA Approves Botox to Treat Urinary Incontinence in People with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury -- American Academy of Neurology
aan.com — “The U.S. Food and Drug Administration approves Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder. Read the FDA news release.” View full resource at aan.com
Most Recently Shared on August 28, 2011 at 12:14 pm By:
FDA Approves Botox to Treat Urinary Incontinence in People with Neurological Conditions Including Multiple Scler... http://t.co/hODwJW9
Allergan gets FDA nod for use of Botox in urinary incontinence
news-medical.net — “Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 10:18 pm By:
Allergan gets FDA nod for use of Botox in urinary incontinence: Allergan Inc. has received United States Food an... http://t.co/ANHoTem
Allergan receives FDA approval for Botox to treat specific form of urinary incontinence
news-medical.net — “The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 10:30 am By:
Urology & Nephrology OW Health
Allergan receives FDA approval for Botox to treat specific form of urinary incontinence: The U.S. Food and Drug ... http://t.co/wMEM3gt
FDA OKs Botox for certain bladder control issues
health.yahoo.net — “The Food and Drug Administration says it has approved Allergan's Botox injection for a new use in patients who have bladder problems caused by spinal cord injury or multiple sclerosis.” View full resource at health.yahoo.net
Most Recently Shared on August 24, 2011 at 9:40 pm By:
FDA OKs Botox for certain bladder control issues http://t.co/opi2cO9
FDA OKs Botox for certain bladder control issues
health.yahoo.net — “The Food and Drug Administration says it has approved Allergan's Botox injection for a new use in patients who have bladder problems caused by spinal cord injury or multiple sclerosis.” View full resource at health.yahoo.net
Most Recently Shared on August 24, 2011 at 9:11 pm By:
Jane Anderson Healthy Eating Advisor
FDA OKs Botox for certain bladder control issues http://t.co/vOAbTsW
FDA OKs Botox for certain bladder control issues
health.yahoo.net — “The Food and Drug Administration says it has approved Allergan's Botox injection for a new use in patients who have bladder problems caused by spinal cord injury or multiple sclerosis.” View full resource at health.yahoo.net
Most Recently Shared on August 24, 2011 at 9:09 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
FDA OKs Botox for certain bladder control issues: The Food and Drug Administration says it has approved Allergan... http://t.co/ekMYLxc
FDA approves Botox for certain bladder control issues - USATODAY.com
yourlife.usatoday.com — “The Food and Drug Administration says it has approved Allergan's Botox injection for a new use in patients who have bladder problems caused by spinal cord injury or multiple sclerosis.” View full resource at yourlife.usatoday.com
Most Recently Shared on August 24, 2011 at 8:39 pm By:
FDA approves Botox for certain bladder control issues http://t.co/FIYVlL8
FDA Approves Botox to Treat Specific Form of Urinary Incontinence
drugs.com — “Botox (onabotulinumtoxinA) is used to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.. Includes Botox side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 24, 2011 at 8:07 pm By:
Drugs and Devices OW OW Health
FDA Approves Botox to Treat Specific Form of Urinary Incontinence: SILVER SPRING, Md., Aug. 24, 2011 /PRNe... http://t.co/6CUMTtr #drug
PharmaLive: FDA approves supplemental new drug application for Novartis therapy Gilenya to include data showing reduction in T1 lesions in MS, a marker of disease activity
pharmalive.com — “PharmaLive: FDA approves supplemental new drug application for Novartis therapy Gilenya to include data showing reduction in T1 lesions in MS, a marker of disease activity” View full resource at pharmalive.com
Most Recently Shared on August 3, 2011 at 12:04 am By:
Novartis MS drug Gilenya gets new label info: Data on reduced T1 lesions, a marker for disease activity. http://bit.ly/q43Gfm
Medical News: FDA Okays New Label Claim for Fingolimod - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “The oral multiple sclerosis drug fingolimod (Gilenya) reduces T1 gadolinium-enhancing lesions on MRI scans, according to new label language cleared by the FDA.” View full resource at medpagetoday.com
Most Recently Shared on August 2, 2011 at 11:00 pm By:
FDA Okays New Label Claim for Fingolimod: (MedPage Today) -- The oral multiple sclerosis drug… http://goo.gl/fb/BQdIf
Advertisement
